Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Risek Insta - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Risek Insta

Approved

STANDARD

Risek Insta

Getz Pharma (Pvt) Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: b3008cb9c69b4b6f
Company: Getz Pharma (Pvt) Ltd.
Type: Standard

Approval Details

Approval Id: b3008cb9c69b4b6f
Drug Approval Philippines Name: Risek Insta
Product Name: Risek Insta
Registration Number: DR-XY42835
Brand Name: Risek Insta
Generic Name: Omeprazole + Sodium Bicarbonate
Dosage Form: Powder For Oral Suspension
Dosage Strength: 40mg / 1680mg
Manufacturer: Getz Pharma (Pvt) Ltd.
Importer: Getz Pharma (Phils.), Inc.
Distributor: Getz Pharma (Phils.), Inc.
Issuance Date: 26 April 2023
Expiry Date: 18 October 2028
Pharmacologic Category: Proton Pump Inhibitor
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

b3008cb9c69b4b6f

Type

Standard

Back to Philippines FDA Approvals